- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02462681
Ketamine as Adjunctive Analgesic With Bupivacaine in Paravertebral Analgesia for Breast Cancer Surgery
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Breast cancer is perhaps the most common cancer in women that requires frequent surgical intervention. Nearly 40% of post-operative breast surgery patients experience significant acute post-operative pain, with a pain score above five reflecting inadequacy of conventional pain management. Most of the responses of the human body to post-surgical pain have been proven to be detrimental to the patient's homeostasis and recovery. Moreover, the incidence of chronic postoperative pain in breast surgery patients is as high as 50% and inadequate analgesia is considered as an independent risk factor. Hence, a number of therapeutic measures have been accepted as a part of the "multi-modal" approach to post-operative pain control. Thoracic Paravertebral Block (PVB) is used for pain relief after thoracotomy , and mastectomy. PVB can provide profound, long lasting sensory differentiation. The resulting greater attenuation of surgical stress response may translate into reduced inotropic stimulation of the heart. Additionally, unlike general anesthesia, PVB can provide superior postoperative analgesia, less nausea and vomiting, shorter recovery time; require fewer analgesic, earlier mobilization, and earlier home readiness for discharge. The use of PVB in patients undergoing ambulatory breast surgery has cost-saving potential. There is little systematic research on the efficacy and tolerability of the addition of adjunctive analgesic agent in paravertebral analgesia. The addition of adjunctive analgesics, such as fentanyl and clonidine to local anesthetics has been shown to enhance the quality and duration of sensory neural blockade, and decrease the dose of local anesthetic and supplemental analgesia .
Ketamine is an anaesthetic agent with potent analgesic properties. Its mode of action includes noncompetitive antagonism at N-methyl d-aspartate (NMDA) receptors and a local anaesthetic effect. ketamine has been extensively used through epidural and caudal routes with variable results.It possesses some definite advantages over the conventional local anaesthetic agents as it stimulates cardiovascular system and respiratory system.The advantages of ketamine include a good analgesic effect, cardio vascular stability in a hypotensive state, bronchodilatation in asthmatics, and the absence of awareness. Disadvantages include increased heart rate and blood pressure, emergence phenomenon, laryngospasm and apnea, increases in intracranial and intraocular pressure, and the lack of visceral anesthesia.
Study Type
Enrollment (Actual)
Phase
- Phase 2
- Phase 1
Contacts and Locations
Study Locations
-
-
-
Assiut, Egypt, 171516
- Assiut University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- all patients scheduled for elective modified radical mastectomy with axillary dissection will be enrolled in the study
Exclusion Criteria:
- patients with a known allergy to the study drugs
- patients with bleeding diathesis
- patients with infection at the site of injection
- patients with central neuropathy
- patients with liver impairment
- patients with renal impairment
- drugs or alcohol abusers
- patients with psychiatric illnesses
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: bupivacaine group in paravertebral block
patients will be received 20 ml of bupivacaine 0.25% paravertebrally, divided into 3-4 ml in each level
|
Thoracic paravertebral blocks will be performed as described by Moore and Katz.
Intradermal lidocaine will be used at the site of the needle insertion.
The superior aspect of the spinous processes of T1- T6 will be marked.
The skin entry points will 3 cm laterals to the marks.
A 22- gauge quincke spinal needle attach to extension tubing to a syringe containing study drugs will be used.
The needle will be inserted perpendicular to the skin for a distance of 2 to 4 cm until the transverse process will contact.
The needle will be withdrawn and walk cephalad off the transverse process and advance for a further 1.5 to 2 cm.
Other Names:
|
Active Comparator: bupivacaine + 0.5 mg/kg ketamine group in paravertebral block
patients will be received 20 ml of bupivacaine 0.25% + 0.5 mg/kg ketamine paravertebrally divide into 3-4 ml in each level
|
Thoracic paravertebral blocks will be performed as described by Moore and Katz.
Intradermal lidocaine will be used at the site of the needle insertion.
The superior aspect of the spinous processes of T1- T6 will be marked.
The skin entry points will 3 cm laterals to the marks.
A 22- gauge quincke spinal needle attach to extension tubing to a syringe containing study drugs will be used.
The needle will be inserted perpendicular to the skin for a distance of 2 to 4 cm until the transverse process will contact.
The needle will be withdrawn and walk cephalad off the transverse process and advance for a further 1.5 to 2 cm.
Other Names:
|
Active Comparator: bupivacaine + 1 mg/kg ketamine group in paravertebral block
patients will be received 20 ml of bupivacaine 0.25% + 1mg/kg ketamine paravertebrally divide into 3-4 ml in each level
|
Thoracic paravertebral blocks will be performed as described by Moore and Katz.
Intradermal lidocaine will be used at the site of the needle insertion.
The superior aspect of the spinous processes of T1- T6 will be marked.
The skin entry points will 3 cm laterals to the marks.
A 22- gauge quincke spinal needle attach to extension tubing to a syringe containing study drugs will be used.
The needle will be inserted perpendicular to the skin for a distance of 2 to 4 cm until the transverse process will contact.
The needle will be withdrawn and walk cephalad off the transverse process and advance for a further 1.5 to 2 cm.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
changes in pain intensity score from baseline
Time Frame: at 2,4,6,12,24,36and 48 hour postoperatively
|
Visual analogue scale (VAS) Scored from 0-10 (where 0= no pain and 10= the worst pain imaginable) as it measured as VAS at rest (VAS.R) and during movement or ipsilateral arm abduction (VAS.M)
|
at 2,4,6,12,24,36and 48 hour postoperatively
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
side effect
Time Frame: 2,4,6,12,24,36and 48 hour postoperatively.
|
nausea, vomiting, hypotension, bradycardia, sedation, dizziness and nystagmus will recorded and treated also postoperative complications of the block such as accidental pneumothorax and vascular puncture will be recorded and treated
|
2,4,6,12,24,36and 48 hour postoperatively.
|
chronic neuropathic pain
Time Frame: 1st,2nd and 3rd postoperative months
|
(Douleur Neuropathique 4 questions) (DN4) questionnaire will be used for assessment of development of neuropathic pain
|
1st,2nd and 3rd postoperative months
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Sahar A. Mohamed, MD, Lecturer of anesthesia, ICU and pain management- South Egypt Cancer Institute- Assuit University
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Pain
- Neurologic Manifestations
- Chronic Pain
- Acute Pain
- Physiological Effects of Drugs
- Neurotransmitter Agents
- Molecular Mechanisms of Pharmacological Action
- Central Nervous System Depressants
- Peripheral Nervous System Agents
- Analgesics
- Sensory System Agents
- Anesthetics, Dissociative
- Anesthetics, Intravenous
- Anesthetics, General
- Anesthetics
- Excitatory Amino Acid Antagonists
- Excitatory Amino Acid Agents
- Ketamine
Other Study ID Numbers
- 211
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chronic Pain
-
Pain ConcernThe Thistle Foundation; Health and Social Care Alliance Scotland (the ALLIANCE) and other collaboratorsCompletedChronic Pain | Chronic Pain Syndrome | Chronic Pain, Widespread | Chronic Pain Due to Trauma | Chronic Pain Due to Malignancy (Finding) | Chronic Pain Due to Injury | Chronic Pain Post-Procedural | Chronic Pain HipUnited Kingdom
-
Vastra Gotaland RegionCompletedPain, Chronic | Widespread Chronic PainSweden
-
Dow University of Health SciencesRecruitingLow Back Pain | Chronic Low-back Pain | Low Back Pain, Mechanical | Mechanical Low Back Pain | Pain, Chronic | Pain, Back | Lower Back Pain Chronic | CLBP - Chronic Low Back PainPakistan
-
Consorci Sanitari de l'Alt Penedès i GarrafRecruitingChronic Post Operative Pain | Chronic Post-surgical Pain | Chronic Knee PainSpain
-
University of UtahRecruitingChronic Pain | Chronic Pain Syndrome | Widespread Chronic PainUnited States
-
University of Alabama, TuscaloosaPatient-Centered Outcomes Research Institute; East Carolina University; Whatley...CompletedPain | Chronic Pain | Chronic Pain Syndrome | Widespread Chronic Pain | Chronic Pain Due to InjuryUnited States
-
Societa Italiana Anestesia Analgesia Rianimazione...RecruitingPost Operative Pain | Postoperative Pain, Chronic | Post Surgical PainItaly
-
Atatürk Chest Diseases and Chest Surgery Training...RecruitingPostoperative Pain | Thoracotomy | Postoperative Pain, Acute | Postoperative Pain, ChronicTurkey
-
Evolve Restorative CenterFlowonix Medical; Celéri Health, Inc.; Advanced Infusion SolutionsCompletedPain, Chronic | Pain, Intractable | Chronic Nonmalignant PainUnited States
-
Assiut UniversityNot yet recruiting
Clinical Trials on paravertebral block
-
Makassed General HospitalRecruiting
-
Bakirkoy Dr. Sadi Konuk Research and Training HospitalCompletedVideo-assisted Thoracoscopic Surgery | Postoperative Analgesia | Thoracic Paravertebral BlockTurkey
-
Larissa University HospitalUnknownBreast Surgery | Autonomic Nervous System | Thoracic Paravertebral Block | HRVGreece
-
Huazhong University of Science and TechnologyRecruitingPain, Acute | Nerve Block | Thoracic AnesthesiaChina
-
Assiut UniversityCompletedRenal Stone | Percutaneous | NephrolithotomyEgypt
-
Assiut UniversityRecruitingKidney Stones | Percutaneous NephrolithotomyEgypt
-
Tanta UniversityCompleted
-
University Hospital, RouenCompletedAnesthesia | Video Assisted ThoracoscopyFrance